Wells Fargo’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $248K | Sell |
29,863
-39,348
| -57% | -$408K | ﹤0.01% | 4579 |
|
|
2025
Q4 | $855K | Buy |
69,211
+17,107
| +33% | +$183K | ﹤0.01% | 4087 |
|
|
2025
Q3 | $460K | Buy |
52,104
+6,413
| +14% | +$49.9K | ﹤0.01% | 4367 |
|
|
2025
Q2 | $292K | Buy |
45,691
+34,615
| +313% | +$198K | ﹤0.01% | 4522 |
|
|
2025
Q1 | $53.8K | Buy |
11,076
+2,729
| +33% | +$22.6K | ﹤0.01% | 5369 |
|
|
2024
Q4 | $79.8K | Sell |
8,347
-11,665
| -58% | -$107K | ﹤0.01% | 5321 |
|
|
2024
Q3 | $167K | Buy |
20,012
+16,477
| +466% | +$150K | ﹤0.01% | 4696 |
|
|
2024
Q2 | $24.1K | Sell |
3,535
-18,771
| -84% | -$80.8K | ﹤0.01% | 5531 |
|
|
2024
Q1 | $56.4K | Buy |
22,306
+2,506
| +13% | +$5.65K | ﹤0.01% | 5208 |
|
|
2023
Q4 | $47.5K | Buy |
19,800
+2,430
| +14% | +$5.71K | ﹤0.01% | 5294 |
|
|
2023
Q3 | $59.1K | Sell |
17,370
-110,265
| -86% | -$611K | ﹤0.01% | 5094 |
|
|
2023
Q2 | $938K | Buy |
127,635
+37,261
| +41% | +$346K | ﹤0.01% | 3520 |
|
|
2023
Q1 | $936K | Buy |
90,374
+71,435
| +377% | +$863K | ﹤0.01% | 3419 |
|
|
2022
Q4 | $224K | Buy |
18,939
+8,252
| +77% | +$128K | ﹤0.01% | 4114 |
|
|
2022
Q3 | $224K | Sell |
10,687
-164,923
| -94% | -$4.59M | ﹤0.01% | 4180 |
|
|
2022
Q2 | $5.45M | Sell |
175,610
-113,540
| -39% | -$3.88M | ﹤0.01% | 2035 |
|
|
2022
Q1 | $11.9M | Sell |
289,150
-26,682
| -8% | -$1.18M | ﹤0.01% | 1698 |
|
|
2021
Q4 | $13.7M | Sell |
315,832
-101,319
| -24% | -$4.58M | ﹤0.01% | 1611 |
|
|
2021
Q3 | $20.9M | Buy |
417,151
+126,093
| +43% | +$7.64M | ﹤0.01% | 1633 |
|
|
2021
Q2 | $18.3M | Sell |
291,058
-170,494
| -37% | -$11M | ﹤0.01% | 1737 |
|
|
2021
Q1 | $42.9M | Buy |
461,552
+18,255
| +4% | +$1.87M | 0.01% | 1131 |
|
|
2020
Q4 | $39.7M | Sell |
443,297
-164,414
| -27% | -$15.1M | 0.01% | 1115 |
|
|
2020
Q3 | $62.8M | Buy |
607,711
+140,558
| +30% | +$15.2M | 0.02% | 764 |
|
|
2020
Q2 | $36.9M | Sell |
467,153
-2,074
| -0.4% | -$155K | 0.01% | 1014 |
|
|
2020
Q1 | $27.1M | Buy |
469,227
+158,422
| +51% | +$9.13M | 0.01% | 1081 |
|
|
2019
Q4 | $16.8M | Sell |
310,805
-20,316
| -6% | -$1.1M | ﹤0.01% | 1578 |
|
|
2019
Q3 | $17.3M | Sell |
331,121
-13,070
| -4% | -$609K | ﹤0.01% | 1531 |
|
|
2019
Q2 | $16.6M | Buy |
344,191
+187,359
| +119% | +$8.98M | ﹤0.01% | 1578 |
|
|
2019
Q1 | $7.92M | Buy |
156,832
+10,342
| +7% | +$610K | ﹤0.01% | 2121 |
|
|
2018
Q4 | $8.69M | Sell |
146,490
-494
| -0.3% | -$31.8K | ﹤0.01% | 1954 |
|
|
2018
Q3 | $9.68M | Buy |
146,984
+9,395
| +7% | +$548K | ﹤0.01% | 2095 |
|
|
2018
Q2 | $6.95M | Sell |
137,589
-9,768
| -7% | -$509K | ﹤0.01% | 2393 |
|
|
2018
Q1 | $7.76M | Buy |
147,357
+15,052
| +11% | +$750K | ﹤0.01% | 2235 |
|
|
2017
Q4 | $6.15M | Buy |
132,305
+41,169
| +45% | +$1.73M | ﹤0.01% | 2409 |
|
|
2017
Q3 | $3.69M | Buy |
91,136
+17,324
| +23% | +$627K | ﹤0.01% | 2791 |
|
|
2017
Q2 | $2.5M | Buy |
73,812
+242
| +0.3% | +$7.47K | ﹤0.01% | 3029 |
|
|
2017
Q1 | $2.14M | Sell |
73,570
-30,777
| -29% | -$937K | ﹤0.01% | 3153 |
|
|
2016
Q4 | $3.43M | Sell |
104,347
-146,907
| -58% | -$4.4M | ﹤0.01% | 2705 |
|
|
2016
Q3 | $7.92M | Buy |
251,254
+164,359
| +189% | +$4.78M | ﹤0.01% | 1927 |
|
|
2016
Q2 | $2.44M | Buy |
86,895
+8,312
| +11% | +$326K | ﹤0.01% | 2827 |
|
|
2016
Q1 | $2.86M | Buy |
78,583
+6,610
| +9% | +$233K | ﹤0.01% | 2672 |
|
|
2015
Q4 | $2.88M | Buy |
71,973
+15,882
| +28% | +$554K | ﹤0.01% | 2719 |
|
|
2015
Q3 | $1.6M | Buy |
56,091
+33,577
| +149% | +$1.11M | ﹤0.01% | 3162 |
|
|
2015
Q2 | $742K | Buy |
22,514
+10,121
| +82% | +$314K | ﹤0.01% | 3838 |
|
|
2015
Q1 | $356K | Sell |
12,393
-3,589
| -22% | -$103K | ﹤0.01% | 4141 |
|
|
2014
Q4 | $435K | Buy |
15,982
+51
| +0.3% | +$1.22K | ﹤0.01% | 4023 |
|
|
2014
Q3 | $340K | Sell |
15,931
-1,529
| -9% | -$35K | ﹤0.01% | 4105 |
|
|
2014
Q2 | $392K | Buy |
17,460
+2,098
| +14% | +$48.9K | ﹤0.01% | 4037 |
|
|
2014
Q1 | $388K | Buy |
15,362
+4
| +0% | +$101 | ﹤0.01% | 4012 |
|
|
2013
Q4 | $353K | Sell |
15,358
-96
| -0.6% | -$2K | ﹤0.01% | 3974 |
|
|
2013
Q3 | $294K | Buy |
15,454
+4,565
| +42% | +$81.5K | ﹤0.01% | 4018 |
|
|
2013
Q2 | $157K | Buy |
+10,889
| New | +$158K | ﹤0.01% | 4234 |
|
Other funds holding EBS
VCM
PCM
VPM
Wells Fargo's EBS Position: Q1 2026 in Review
Wells Fargo reduced its Emergent Biosolutions (EBS) stake by 57% in Q1 2026, selling an estimated $408K and leaving 29,863 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #4579.
Wells Fargo first reported a position in EBS in Q2 2013 and has held it in 52 quarters since. The position peaked at $62.8M in Q3 2020. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.
- Wells Fargo held 29,863 shares of Emergent Biosolutions worth $248K as of Q1 2026.
- Wells Fargo sold 39,348 Emergent Biosolutions shares in Q1 2026, an estimated $408K.
- Emergent Biosolutions made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4579 holding.
- Wells Fargo first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's Emergent Biosolutions position peaked at $62.8M in Q3 2020.
- 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.